Collegium Pharmaceutical Stock News

Legal & General Group Plc lowered its stake in Collegium Pharmaceutical Inc (NASDAQ:COLL) by 19.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The instit

H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Zynerba Pharmaceuticals (ZYNE – Research Report) today and set a

In a report released today, Serge Belanger from Needham downgraded Zynerba Pharmaceuticals (ZYNE – Research Report) to Hold. The company’s

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on G1 Therapeutics

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sol-Gel Technologies

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Verrica Pharmaceuticals

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Novan (NOVN

In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report),

AMRX vs. COLL: Which Stock Is the Better Value Option?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing

In a report released today, Serge Belanger from Needham assigned a Buy rating to Collegium Pharmaceutical (COLL – Research Report),

Collegium Pharmaceutical, Inc. (COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has been named one of Boston Business Jo

STOUGHTON, Mass., June 17, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Momenta Pharma

AMRX vs. COLL: Which Stock Is the Better Value Option?